Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases

NCT05477927 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Malignant Peritoneal Effusion
Malignant Ascites
Serous Cavity Metastatises

Interventions

BIOLOGICAL: Dual-targeting VEGFR1 and PD-L1 CAR-T cells

Sponsor

Sichuan University